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Abstract 
Background: Diabetes is a major cause of blindness in developed and developing world. Cataract is increased in 
frequency in diabetics and makes an important contribution to diabetic blindness. With OCT various parameters of 
macula can be obtained which helps in understanding of relationship of macular status before and after cataract 
surgery.Objectives: This study uses OCT to compare cystoid macular oedema after cataract surgery in diabetic and 
non diabetic patients.Methods: This prospective, comparative study was conducted on 100 patients during October 
2017 to September 2018. Patients were divided into Group I (50 eyes of metabolically controlled diabetic patients) 
and Group II (50 eyes of non diabetic patients). OCT was used to assess macular oedema in both groups 




 month. Results: In Group I, the mean foveal thickness significantly 
increased by 13% and 8.9% from the baseline at 1 and 3 months respectively (p= 0.001, 0.003). In Group II the 
mean foveal thickness increased by 10.4% and 7% from the baseline at 1 and 3 months. (p= 0.001, p=0.022). The 
difference in increase in mean foveal thickness between Group I and Group II was statistically significant at 1 and 3 
months (p=0.005, p=0.001) respectively.Conclusion: The results in our study suggest that OCT is effective tool in 
estimating the post operative macular oedema and should be done if available to get baseline macular status and 
diagnosis. The preoperative evaluation of macular status in diabetics by OCT is important in determining post 
operative visual gain. 
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Introduction  
 
Diabetes mellitus is emerging as the single largest 
cause of blindness in developing countries[1,2]. 
Diabetes currently affects more than 62 million  
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Indians, which is more than 7.1 % of adult 
population[3-5].Macular oedema (ME) is a common 
cause of blindness after cataract surgery.  Macular 
oedema is caused by increased vascular permeability in 
retinal capillaries as well as from microaneurysms[6]. 
Macular oedema can be observed with slit lamp 
biomicroscopy using +78D lens, while Optical 
Coherence Tomography (OCT) delineates the lesion 
much better.In diabetic adults, cataract is more 
prevalent and progression is more rapid. There is 
controversy regarding effects of phacoemulsification 
on retina in diabetics, with some studies suggesting 
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adverse effect on progression of diabetic retinopathy 
and macular oedema and others suggesting it is the due 
to natural history of the disease. Due to altered blood 
retinal barrier and presence of diabetic retinopathy, 
incidence of macular oedema is also increasing[7]. 
Optical Coherence Tomography is a new digital 
imaging technique first described in 1991. OCT 
provides high resolution and cross-sectional imaging of 
macula[8]. OCT compared to other tests is objective 
and takes only few seconds to perform. OCT quantifies 
the macular thickness at a resolution of approximately 
10 µm axial resolution. Thus by using OCT we can 
obtain the relationship of macular status before and 
after cataract surgery in diabetic patients[9,10]. This 
study was designed to compare cystoid macular 
oedema after cataract surgery in diabetic and non 
diabetic patients by using OCT.  
 
Material and methods 
 
Ethics: The study topic was approved from the 
institutional research ethical committee with reference 
number EC/NEW/INST/2019/440. Prospective cases 
were counselled regarding the objectives and 
methodology of the study and their written consent was 
obtained. 
Study design: 
A hospital based, comparative, prospective study based 
on descriptive research design was done during 
October 2017 to September 2018. Patients attending 
department of ophthalmology who were willing for 
cataract surgery, after satisfying the inclusion and 
exclusion criteria were enrolled into the study. 
Inclusion criteria:  
1. All the patients above 40 years with visually 
significant cataract who were scheduled for 
cataract surgery. 
2. Patients with metabolically controlled diabetes 
before surgery.  
3. Grade I and II nuclear sclerosis and cortical 
cataract were included according to LOC III 
classification. 
Exclusion Criteria: 
1. History of trauma, ocular surgery in past 3 months. 
2. Ocular illness like glaucoma,uveitis, vascular 
occlusion, retinitis pigmentosa, retinal detachment. 
3. Patients not completing 3 months of follow-up. 
4. Age <18 years. 
5.  Significantly dense cataract which preclude 
fundus photography and optical coherence 
tomography. 
6. Patient who had received local or systemic steroids 
and local NSAID’s in previous 3 months. 
7. Patients with vitrectomised eyes. 
 
Sample size calculation: From previous study:Torron-
Famandez –Blanco C, Rutz-Moreno O, Ferrer-Novella 
E, Sanchez-Cano A, Honrubia-Lopez FM. 
Pseudophakic cystoid macular edema- Assessment 
with optical coherence tomography. Arch Soc Esp 
Oftalmol 2006; 81(3):147-53 
N = minimum required sample size in each of the 
groups 
Mean central macular thickness in Diabetic 
Group=241.6±56.3 microns 
Mean central macular thickness in Non diabetic 
Group=204.6±21.8 microns 
D = difference in mean central macular thickness 




 = Squared pooled deviation=3042.34  
1.96 = conventional multiplier for alpha 0.05 
1.26 = conventional multiplier for power 90% 
  
Minimum sample size is N=  





 =45(minimum) in each 
group 
Group I = 50  
Group II = 50  
     
Methodology 
 Proforma designing– After detailed review of 
literature, preparation of proforma was done, to 
collect cases. 
 Selection & enrolment of cases – The cases those 
fulfilled predefined inclusion and exclusion 
criteria, enumerated earlier, were enrolled in the 
study.  
Baseline data collection– By using pretested 
proforma, all details were recorded. After getting 
informed consent, preoperative examination was done. 
Standard phacoemusification with acrylic foldable IOL 
in the bag was performed.OCT was done in all the 
patients preoperatively and postoperative 1 and 3 
months. Foveal thickness was calculated and 
comparison was done between Group I and Group II.  
Relevant investigations– – A detailed physical, 
general examination was done. All the patients were 
subjected to systemic investigation including 
haemoglobin, total blood count, differential count, 
urine albumin and sugar, fasting blood sugar, ECG, 
blood pressure. Diabetics were subjected to other tests 
like 24 hour urinary protein; post prandial blood sugar, 
renal function tests, lipid profile. Slit lamp 
biomicroscopy was performed for detail anterior 
segment examination for iris neovascularisation, 
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pupillary reaction, location of cataract, grading of 
cataract according to LOC III.  
At 1 and 3 month visit they had undergone complete 
ocular examination including visual acuity, intra-ocular 
pressure, IOL position, anterior and posterior segment 
examination and OCT.                       
Statistical analysis:    Data was compiled in MS excel 
and checked for its completeness and correctness. 
Statistical analysis was performed with SPSS 18.0 
[Trial version, IBM Statistics]. For continuous data, 
descriptive statistics like mean, mode, median, standard 
deviation, range was calculated. For categorical data 
number and percentage was analyzed. Data was 
checked for Normality using Shaipro – Wilk test of 
Normality. For Non- Normal data, Mann-Whitney U 
test and  Wilcoxon signed rank test was used. P Value 
of <0.05 was taken as significant. 
Results  
In Group I, 28 (56%) patients were below 60 years and 
22 (44%) were above 60 years and in Group II, 34 (68 
%) patients were below 60 years and 16 (32%) were 
above 60 years. The mean age of Group I patients was 
57.82± 7.9 years (range 43-81) and of Group II was 
55.80±6.6 years (range 47-71).    There were 20 (40%) 
females and 30(60%) males in Group I, while in Group 
II there were 18(36%) females and 32 (64%) males. 
Both the groups were comparable for age and sex 
distribution.It is evident from Table 1 that, Group I, the 
mean foveal thickness was 205.86µm preoperatively 
which increased to 233.14µm at 1 month and 
224.14µm at 3 months. The increase was significantly 
higher by 13% and 8.9% from the baseline at 1 and 3 
months respectively (p= 0.001, 0.003). In Group II the 
mean preoperative foveal thickness was 165.18µm 
which increased to 182.28µm at 1 month and 
176.66µm at 3 months.  The increase was significantly 
higher by 10.4% and 7% from the baseline at 1 and 3 
months. (p= 0.001, p=0.022).As shown in Table 2,the 
difference in increase in foveal thickness between 
Group I and Group II was statistically significant at 1 
and 3 months (p=0.005, p=0.001) respectively.From 
Table 3 it is clear that, the difference between final 
visual acuity at 1and 3 months between the two groups 
was not significant. (p=0.657, 0.359).It is evident from 
Table 4(a) that the incidence of post operative cystoid 
macular oedema in Group I is 22% (n=11). As shown 
in Table 4(b) the incidence in Group II is 8% (n= 4).  
Discussion 
The mean age in our study was 57.82 and 55.80 in 
Group I and Group II respectively, which was younger 
age group as compared to other studies[11,12] where 
the  mean age was ranging between 68 to 76 years. 
Male to female ratio was 1.6:1 in our study which is 
comparable to other study. In our study foveal 
thickness was maximum at 1 month and decreased at 3 
month but did not return to baseline which was 
consistent with the result by Kim SJ et al[11] .  In a 
study by Jurecka T et al[10] they did 6 month follow 
up and found normalisation of retinal thickness at 6 
months. Jurecka T et al[13] did similar comparison 
among diabetics and non diabetics which was similar 
to our study. The difference in increase in foveal 
thickness between Group I and Group II was 
statistically significant at 1 and 3 months (p=0.005, 
p=0.001) respectively. In our study the difference in 
final visual acuity between diabetics and non diabetics 
was not statistically significant (p= 0.359). In a study 
by Jurecka T et althe results were comparable to our 
study.The incidence of CME in diabetic was 22% in 
present study which was similar as compared to study 
by Kim SJ et al[11] on diabetics (22%). However Kim 
SJ et al
 
[11] defined CME as increase of foveal 
thickness by greater than 30% from the baseline and 
did not consider cystoid  spaces as our study did. The 
incidence of CME in diabetics in a report by Pedro 
Romero- Aroca et al[14] was very less as compared to 
our study (1.52%).The incidence of CME in non-
diabetics was 8% in the present study, similar to study 
by Menetes J  et al (9%) and higher than a study by 
Jurecka T et al (3%) on non-diabetics[15]. The 
increased incidence of CME is attributed to defective 
blood retinal barrier and higher levels of VEGF in 
diabetics[13]It was thus observed that all the patient’s 
diabetic and non diabetic showed increase in foveal 
thickness after uncomplicated phacoemulsification. 
The incidence of CME was statistically more in 
diabetics as compared to non diabetics after 
uncomplicated phacoemulsification. The diabetic CME 
eyes had significantly less final visual acuity than non 
diabetic CME eyes at three months.  
 
Conclusion 
 The results in our study suggest that OCT is effective 
tool in estimating the post operative macular oedema 
and should be done if available to get baseline macular 
status and diagnosis. The preoperative evaluation of 
macular status in diabetics by OCT is important in 
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Table 1: Foveal thickness preoperatively, at 1month and 3 months 
Foveal thickness Preoperative 1 month 3 month 
Group I 205.86±111.67 233.14±134.62 224.14±105.87 
Group II 165.10±29.13 182.28±44.20 176.66±38.43 
 
Table 2: Comparison of foveal thickness between group I and group II at 1 and 3 months 
Comparison of foveal thickness  between Groups at 1 and 3 months 





Z P value 
FT1 
Group I 50 233.14 134.623 19.039 
840.000 -2.827 0.005 
Group II 50 182.28 44.209 6.252 
FT3 
Group I 50 224.14 105.875 15.125 
759.000 -3.262 0.001 
Group II 50 176.66 38.437 5.436 
 
Table 3: Comparison of visual acuity in both groups at 1 and 3 months postoperatively 
Comparison between groups 





Z P value 
VN1 
Group I 50 0.13 0.246 0.035 
1193.500 -0.444 0.657 
Group II 50 0.11 0.178 0.025 
VN3 
Group I 50 0.10 0.225 0.032 
1149.000 -0.917 0.359 
Group II 50 0.05 0.113 0.016 
 
Table 4(a): Cystoid macular edema in group I 
CME IN GROUP I Frequency Percent 
Absent 39 78.0 
Present 11 22.0 
Total 50 100.0 
 
Table 4(b): Cystoid macular edema in group II 
 CME IN GROUP II                                Frequency                    Percent 
Absent 46 92.0 
Present 4 8.0 
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